Healthcare Realty Trust stock hits 52-week low at $14.44

Healthcare Realty Trust (HR) shares have hit a 52-week low of $14.44 following a larger-than-expected EPS loss of -$0.13 in Q1 2025, despite slightly surpassing revenue expectations at $298.98 million. The company, which maintains an 8.28% dividend yield and has paid dividends for 33 years, reaffirmed its full-year normalized FFO per share guidance of $1.56 to $1.60 and plans to dispose of $400-500 million in assets as part of a strategic shift under new CEO Peter Scott, focusing on outpatient medical real estate and portfolio optimization amid investor concerns about balance sheet deleveraging.

Analysis

Healthcare Realty Trust (HR) has reached a new 52-week low of $14.44, reflecting a significant -8.59% share price decline over the past year as the $5.15 billion healthcare REIT contends with market headwinds, including rising interest rates and shifting demand dynamics within the healthcare real estate sector. Despite this pressure, the company highlights an 8.28% dividend yield, underpinned by 33 consecutive years of dividend payments. First-quarter 2025 financial results were mixed: revenues of $298.98 million marginally surpassed the $298.56 million expectation, but earnings per share came in at -$0.13, a wider loss than the -$0.07 forecasted. Importantly, Healthcare Realty reaffirmed its full-year normalized Funds From Operations (FFO) per share guidance of $1.56 to $1.60. Under the leadership of new President and CEO Peter Scott, the company is pursuing a strategic focus on outpatient medical real estate, coupled with a plan to dispose of $400-500 million in assets to optimize its portfolio and address balance sheet deleveraging and margin improvements, areas of inquiry for analysts from firms like Wedbush and Citi. While InvestingPro analysis suggests the stock is fairly valued, the overall sentiment surrounding the stock is negative, and the market tone is cautious.

Key Decisions for Investors

• Investors should carefully weigh Healthcare Realty Trust's attractive 8.28% dividend yield and consistent payment history against the risks highlighted by its 52-week low stock price, the Q1 2025 EPS miss, and persistent sector-specific challenges such as rising interest rates.
• Closely monitor the execution and impact of the announced $400-500 million asset disposal program on the company's balance sheet deleveraging efforts and FFO generation, as these are critical components of the new CEO's strategic plan and potential catalysts for a stock recovery.
• Factor in the reaffirmed full-year FFO guidance of $1.56 to $1.60 per share and InvestingPro's 'fairly valued' assessment, while maintaining a cautious stance due to the prevailing negative sentiment and ongoing market pressures impacting the healthcare real estate sector.